Recent Headlines
It’s still too soon to try to genetically edit human embryos because the science isn’t advanced enough to ensure safety, an international panel of experts says.
-
Dozens of major hospitals may ignore an FDA decision allowing use of plasma from recovered COVID-19 patients in order to focus on a clinical trial.
-
The number of mammoth skeletons recovered at an airport construction site north of Mexico City has risen to 200, with more discoveries expected.
-
The prevalence of depression symptoms in the U.S. has more than tripled in the COVID-19 era compared to the period before the pandemic.
Underfunded health departments say they lack the staff, money and tools to distribute, administer and track doses of COVID-19 vaccine for millions of people.
Studies confirm that multiple types of steroids improve survival for severely ill COVID-19 patients, cementing the cheap drugs as a standard of care.
Scientists had thought black holes came in only two sizes: very large and relatively small. But a cosmic merger has revealed a black hole that’s in between.
A COVID-19 vaccine could be available earlier than expected if ongoing clinical trials produce overwhelmingly positive results, Dr. Anthony Fauci said.
Antibodies that fight coronavirus infection last at least four months and do not fade quickly as some earlier reports suggested — a good sign for vaccines.
Tests that look for the coronavirus in samples of saliva are about as reliable as tests that require a sample from the back of the nose, two new studies show.
He returned to his native Namibia again and again to teach science classes to young people.
The social distancing that tamps down the coronavirus could also keep many people from getting the flu.
Health news, science articles, advice and recent articles and commentary.
Most Read
-
Dozens of major hospitals may ignore an FDA decision allowing use of plasma from recovered COVID-19 patients in order to focus on a clinical trial.
-
A COVID-19 vaccine could be available earlier than expected if ongoing clinical trials produce overwhelmingly positive results, Dr. Anthony Fauci said.
-
The prevalence of depression symptoms in the U.S. has more than tripled in the COVID-19 era compared to the period before the pandemic.
Food and Drug Administration and Centers for Disease Control and Prevention are under fire over decisions that seem based on politics, not science.
California health officials prepare for a potential third surge of coronavirus cases fueled by essential workers and young people.
More Coverage
After 8 workers die of coronavirus, officials want Foster Farms plant closed
More than 580,000 along the Gulf Coast were told to evacuate ahead of Hurricane Laura. Will evacuees spread COVID-19?
COVID-19 has upended the education of future doctors, especially third- and fourth-year medical students who should be doing their core clinical training now.
The Food and Drug Administration on Wednesday authorized the first rapid coronavirus test that doesn’t need any special computer equipment to get results.
In the Southern Hemisphere, efforts to stop COVID-19’s spread also blocked transmission of the flu. Can a ‘twindemic’ be avoided up north as well?
Doctors at Harbor-UCLA are participating in a COVID-19 vaccine trial, and they’re aiming to recruit people of color and members of other high-risk groups.
It’s official, California: COVID-19 has left us sick with worry and increasingly despondent. And young adults — ages 18 to 29 — are feeling it worst.
Medicine
Results from the Phase 1 clinical trial of Moderna’s coronavirus vaccine show it’s on the right track, though there were serious side effects at high doses.
-
Scientists have devised a way to use the plasma of COVID-19 survivors for an upper arm injection that could inoculate people against the virus.
-
The steroid dexamethasone can be lifesaving for patients with severe COVID-19. It may also help researchers learn more about the disease and how to treat it.
-
China races against the U.S. and others to make the COVID-19 vaccine first, promoting itself as a benevolent vaccinator for the developing world.
-
The global race for a coronavirus vaccine involves a few basic approaches. Some have been around for decades, others are being tried for the first time.
-
Amid the fear and uncertainty brought on by the coronavirus, doctors and nurses are using narrative medicine to communicate more openly with their patients.
More headlines
-
FDA Commissioner Stephen Hahn apologized for overstating the lifesaving benefits of treating COVID-19 patients with convalescent plasma.
-
The World Health Organization is cautioning that using blood plasma from COVID-19 survivors to treat other patients is still experimental therapy.
-
Fire is like COVID-19. The only response that works is systemic preparedness.
-
The man’s second SARS-CoV-2 infection was detected in an airport screening as he returned to Hong Kong from Europe.
-
One of the hallmarks of the COVID-19 pandemic in the United States is that it disproportionately strikes people of color. But it doesn’t have to be that way.
-
More COVID-19 patients are choosing to be treated where they feel safest: at home.
-
A satellite study has found that Greenland lost 586 billion tons of ice in a record melt last year — enough to cover California in four feet of water.
-
Pharmacists in all 50 states can now give childhood vaccinations under a new directive aimed at preventing future outbreaks of preventable diseases.
-
Doctors checking comatose COVID-19 patients for signs of a stroke instead stumbled onto a new clue about how the coronavirus may harm the lungs.
-
Changes wrought by the COVID-19 pandemic have upended the lives of millions of dementia patients and their caregivers, who rely on long-standing routines.
-
The incidence of injuries attributed to domestic partner violence rose sharply after the coronavirus outbreak began, and those injuries were more serious.
Get our free Coronavirus Today newsletter
Sign up for the latest news, best stories and what they mean for you, plus answers to your questions.
You may occasionally receive promotional content from the Los Angeles Times.